The identification and understanding of small molecule modulators of the lysosomal enzyme, glucocerebrosidase (“GCase”).

Project: Research project

Project Details


LTI’s vision and plan is to develop a mutually supportive relationship with Northwestern where LTI provides research support to NU in order to expand on existing discoveries (such as those regarding glucocerbrosidase) and encourage new discoveries in additional lysosomal disease areas, such as Neimann Pick-C among others
Effective start/end date6/1/145/31/17


  • Lysosomal Therapeutics Inc. (Agmt 6/1/14)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.